A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV

Journal of Virology

Volumn 78, Issue 18, 2004, Pages 10054-10063

  Huang, Zhuhui ^a   Elankumaran, Subbiah ^a   Yunus, Abdul S ^a,b   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b Panacos Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; PROTEIN VP2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE; VIRUS VECTOR;

ANTIBODY RESPONSE; ARTICLE; CELL CULTURE; CHICKEN; CONTROLLED STUDY; GENE INSERTION; GENE LOCUS; GENE THERAPY; HUMORAL IMMUNITY; IMMUNIZATION; INFECTIOUS BURSAL DISEASE VIRUS; NEWCASTLE DISEASE PARAMYXOVIRUS; NEWCASTLE DISEASE PARAMYXOVIRUS VECTOR; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENETICS; VIRION; VIROGENESIS; VIRUS EXPRESSION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BASE SEQUENCE; BIRNAVIRIDAE INFECTIONS; CELL LINE; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; DNA, VIRAL; GENETIC ENGINEERING; HUMANS; INFECTIOUS BURSAL DISEASE VIRUS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINES, SYNTHETIC; VERO CELLS; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; VIRULENCE;

EID: 4444323467     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.18.10054-10063.2004     Document Type: Article

References (48)

1. Alexander, D. J. 1989. Newcastle disease, p. 114-120. In H. G. Purchase, L. H. Arp, C. H. Domermuth, and J. E. Pearson (ed.), A laboratory manual for the isolation and identification of avian pathogens, 3rd ed. American Association for Avian Pathologists, Inc., Kennett Square, Pa.
2. Alexander, D. J. 1997. Newcastle disease and other avian Paramyxoviridae infection, p. 541-569. In B. W. Calnek (ed.), Diseases of poultry, 10th ed. Iowa State University Press, Ames.
3. Azad, A. A., N. M. McKern, I. G. Macreadie, P. Failla, H. G. Heine, A. Chapman, C. W. Ward, and K. J. Fahey. 1991. Physicochemical and immunological characterization of recombinant host-protective antigen (VP2) of infectious bursal disease virus. Vaccine 9:715-722.
4. Becht, H., H. Muller, and H. K. Muller. 1988. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J. Gen. Virol. 69:631-640.
5. Boyle, D. B., and H. G. Heine. 1993. Recombinant fowlpox virus vaccines for poultry. Immunol. Cell Biol. 71:391-397.
6. Bukreyev, A., E. Camargo, and P. L. Collins. 1996. Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J. Virol. 70:6634-6641.
7. Bukreyev, A., S. S. Whitehead, N. Bukreyev, B.R. Murphy, and P. L. Collins. 1999. Interferon γ expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proc. Natl. Acad. Sci. USA 96:367-2372.
8. Calain, P., and L. Roux. 1993. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67:4822-4830.
9. Conzelmann, K. K. 1996. Genetic manipulation of non-segment negative-strand RNA viruses. J. Virol. 77:381-389.
10. De Leeuw, O., and B. Peeters. 1999. Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J. Gen. Virol. 80:131-136.
11. Dodds, W. J. 1999. More bumps on the vaccine road. Adv. Vet. Med. 41:715-732.
12. Fahey, K. J., K. Erny, and J. Crooks. 1989. A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J. Gen. Virol. 70:1473-1481.
13. Haglund, K., J. Forman, H. G. Krausslich, and J. K. Rose. 2000. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology 268:112-121.
14. Hasan, M. K., A. Kato, T. Shioda, Y. Sakai, D. Yu, and Y. Nagai. 1997. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J. Gen. Virol. 78:2813-2820.
15. He, B., R. G. Paterson, C. D. Ward, and R. A. Lamb. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237:249-260.
16. Heine, H. G., and D. B. Boyle. 1993. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Arch. Virol. 131:277-292.
17. Heine, H. G., M. Haritou, P. Failla, K. Fahey, and A. Azad. 1991. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. J. Gen. Virol. 72:1835-1843.
18. Huang, Z., S. Elankumaran, A. Panda, and S. K. Samal. 2003. Recombinant Newcastle disease as a vaccine vector. Poult. Sci. 82:899-906.
19. Huang, Z., S. Krishnamurthy, A. Panda, and S. K. Samal. 2001. High-level expression of a foreign gene from the most 3′-proximal locus of a recombinant Newcastle disease virus. J. Gen. Virol. 82:1729-1736.
20. Huang, Z., S. Krishnamurthy, A. Panda, and S. K. Samal. 2003. Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist. J. Virol. 77:8676-8685.
21. Jackwood, M. W. 1999. Current and future recombinant viral vaccines for poultry. Adv. Vet. Med. 41:517-522.
22. Krishnamurthy, S., Z. Huang, and S. K. Samal. 2000. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278:168-182.
23. Krishnamurthy, S., and S. K. Samal. 1998. Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence. J. Gen. Virol. 79:2419-2424.
24. Lamb, R. A., and D. Kolakofsky. 2001. Paramyxoviridae: the viruses and their replication, p. 1305-1340. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, Pa.
25. Lukert, P. D., and Y. M. Saif. 1991. Infectious bursal disease, p. 648-663. In B. W. Calnek, H. J. Barnes, C. W. Beard, W. M. Reid, and H. W. Yoder, Jr. (ed.), Diseases of poultry. Iowa State University Press, Ames.
26. Mayo, M. A. 2002. A summary of taxonomic changes recently approved by ICTV. Arch. Virol. 147:1655-1656.
27. Mebatsion, T., M. J. Schnell, J. H. Cox, S. Finke, and K. K. Conzelmann. 1996. Highly stable expression of a foreign gene from rabies virus vectors. Proc. Natl. Acad. Sci. USA 93:7310-7314.
28. Mebatsion, T., S. Verstegen, L. T. C. de Vaan, A. Rómer- Oberdórfer, and C. C. Schrier. 2001. A recombinant Newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos. J. Virol. 75:420-428.
29. Nakaya, T., J. Cros, M. S. Park, Y. Nakaya, H. Zheng, A. Sagrera, E. Villar, A. García-Sastre, and P. Palese. 2001. Recombinant Newcastle disease virus as a vaccine vector. J. Virol. 75:11868-11873.
30. Palese, P., H. Zheng, O. G. Engelhardt, S. Pleschka, and A. García-Sastre. 1996. Negative-strand RNA viruses: genetic engineering and applications. Proc. Natl. Acad. Sci. USA 93:11354-11358.
31. Park, K., T. Huang, F. F. Correia, and M. Krystal. 1991. Rescue of a foreign gene by Sendai virus. Proc. Natl. Acad. Sci. USA 88:5537-5541.
32. Peeters, B. P. H., Y. K. Cruthuisen, O. S. de Leeuw, and A. L. Gielkens. 2000. Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch. Virol. 145:1829-1845.
33. Peeters, B. P. H., O. S. de Leeuw, G. Koch, and A. L. Gielkens. 1999. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73:5001-5009.
34. Phenix, K. V., K. Wark, C. J. Luke, M. A. Skinner, J. A. Smyth, K. A. Mawhinney, and D. Todd. 2001. Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development. Vaccine 19:3116-3123.
35. Reddy, S. K., and A. Silim. 1991. Comparison of neutralizing antigens of recent isolates of infections bursal disease virus. Arch. Virol. 117:287-296.
36. Roberts, A., E. Kretzschmar, A. S. Perkins, J. Forman, R. Price, L. Buonocore, Y. Kawaoka, and J. K. Rose. 1998. Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge. J. Virol. 72:4704-4711.
37. Sakaguchi, M., H. Nakamura, K. Sonoda, H. Okamura, K. Yokogawa, K. Matsuo, and K. Hira. 1998. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle disease by one-time vaccination with recombinant vaccine of Marek's disease virus type 1. Vaccine 16:472-479.
38. Sakai, Y., K. Kiyotani, M. Fukumura, M. Asakawa, A. Kato, T. Shioda, T. Yoshida, A. Tanaka, M. Hasegawa, and Y. Nagai. 1999. Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Lett. 456:221-226.
39. Sheppard, M., W. Werner, E. Tsatas, R. McCoy, S. Prowse, and M. Johnson. 1998. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. Arch. Virol. 143:915-930.
40. Snyder, D. B., D. P. Lana, B. R. Cho, and W. W. Marquardt. 1988. Group and strain-specific neutralizing sites of infectious bursal disease virus defined with monoclonal antibodies. Avian Dis. 32:527-534.
41. Snyder, D. B., D. P. Lana, P. K. Savage, F. S. Yancey, S. A. Mengel, and W. W. Marquardt. 1988. Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing antibodies: evidence of a major antigenic shift in recent field isolates. Avian Dis. 32:535-539.
42. Snyder, D. B., V. N. Vakharia, and P. K. Savage. 1992. Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States. Arch. Virol. 127:89-101.
43. Tsukamoto, K., S. Saito, S. Saeki, T. Sato, N. Tanimura, T. Isobe, M. Mase, T. Imada, N. Yuasa, and S. Samaguchi. 2002. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J. Virol. 76:5637-5645.
44. Vakharia, V. N., D. B. Snyder, J. He, G. H. Edwards, P. K. Savage, and S. A. Mengel-Whereat. 1993. Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens. J. Gen. Virol. 74:1201-1206.
45. Vakharia, V. N., D. B. Snyder, D. Lütticken, S. A. Mengel-Whereat, P. K. Savage, G. H. Edwards, and M. A. Goodwin. 1994. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins. Vaccine 12:452-456.
46. Van den Berg, T. P., M. Gonze, and G. Meulemans. 1991. Acute infectious bursal disease in poultry: isolation and characterization of a highly virulent strain. Avian Pathol. 20:133-143.
47. Walsh, E. P., M. D. Baron, J. Anderson, and T. Barrett. 2000. Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein. J. Gen. Virol. 81:709-718.
48. Yokoyama, N., K. Maeda, and T. Mikami. 1997. Recombinant viral vector vaccines for the veterinary use. J. Vet. Med. Sci. 59:311-322.